Things
Cascading call announced by the University of Siena – Spoke 5 “Inflammatory and infectious diseases” in compliance with the provisions of art. 5 of Public Notice no. 3138 of 12/16/2021, as part of the PNRR funding - Mission 4, Component 2 "From research to business", Investment 1.4 "Strengthening research structures and creation of R&D "national champions", relating to the project identified with code CN00000041, entitled “National Center for Gene Therapy and Drugs base
Who is it aimed at?
− Micro, Small and Medium Enterprises (MSMEs), external to the National Center and competing in single mode, having the dimensional parameters referred to in Annex I of REG (EC) no. 800/2008 of the Commission of 6 August 2008 (General block exemption regulation) in OJEU L 214 of 9.8.2008, including innovative start-ups; − Large Enterprises (GI), external to the National Center and which compete in single; − Public research bodies and institutions, including universities and bodies referred to in Legislative Decree no. 218/2016 (https://www.mur.gov.it/it/aree-tematiche/ricerca/il- research-system/public-research-bodies); − Scientific Hospitalization and Care Institutes – IRCCS, which are public or private in nature; − Bodies referred to in the Third Sector Code – Legislative Decree 3 July 2017 n.117 and subsequent amendments.
What does it predict
Through the call it is intended to support research activities in the following areas: Track A - Research Activities (RF, RI) Area 1) Implementation of an RNA-based platform for the development of neutralizing monoclonal antibodies against antimicrobial-resistant bacteria. Specifically, projects for the development of an RNA-based platform aimed at the generation of highly specific and effective monoclonal antibodies to combat antimicrobial-resistant bacteria are being evaluated. Track A – Research Activities (RF, RI) Area 2) Production and analysis of nucleic acid aptamers for the development of new strategies for the delivery of extracellular vesicles containing RNA to tissues/cells of interest in Spoke 5
